G1 Therapeutics Inc (NAS:GTHX)
$ 7.15 0 (0%) Market Cap: 377.22 Mil Enterprise Value: 364.45 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 31/100

Q4 2023 G1 Therapeutics Inc Earnings Call Transcript

Feb 28, 2024 / 01:30PM GMT
Release Date Price: $3.33 (+38.75%)
Operator

Good day, and thank you for standing by, and welcome to the G1 Therapeutics fourth quarter 2023 financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today Will Roberts, Corporate Communications. Please go ahead.

Will Roberts G1 Therapeutics Inc;Communications Officer
IR & Corporate Communications

Thank you, Rivka, and good morning, everyone, and welcome to the G1 conference call to discuss our fourth quarter and full year 2023 financial results and business update. Press release on these financial results was issued this morning and can be found in the news section of our corporate website, g1therapeutics.com.

On this morning's call, the team will provide a business overview of the 2023 fourth quarter and full year, including an update on our clinical programs and our commercial progress in that period with COSELA, which approved and commercially available to decrease the incidence of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot